Upgrade to SI Premium - Free Trial

Contineum Therapeutics (CTNM)

15.49 -0.26 (1.65%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/30/26 *Est.)

Latest Headlines

Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c July 31, 2026 9:18 AM - StreetInsider Contineum Therapeutics (CTNM) PT Raised to $23 at RBC Capital July 31, 2026 8:14 AM - StreetInsider Form 10-Q Contineum Therapeutics, For: Jun 30 July 30, 2026 4:11 PM - SEC Filing Form 8-K Contineum Therapeutics, For: Jul 30 July 30, 2026 4:08 PM - SEC Filing Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones July 30, 2026 4:05 PM - BizWire Form SCHEDULE 13G Contineum Therapeutics, Filed by: BlackRock, Inc. July 27, 2026 4:26 PM - SEC Filing Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC July 17, 2026 5:11 PM - SEC Filing Form 8-K Contineum Therapeutics, For: Jul 13 July 13, 2026 4:15 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jul 08 Filed by: Lorrain Daniel S. July 10, 2026 5:21 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jul 08 Filed by: Stengone Carmine N. July 8, 2026 6:49 PM - SEC Filing Form 144 Contineum Therapeutics, Filed by: Stengone Carmine N. July 8, 2026 4:40 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 30 Filed by: Lorrain Daniel S. July 2, 2026 5:47 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 30 Filed by: Watkins Tim July 1, 2026 7:05 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 30 Filed by: Stengone Carmine N. July 1, 2026 7:04 PM - SEC Filing Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S. July 1, 2026 4:35 PM - SEC Filing Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S. June 30, 2026 4:39 PM - SEC Filing Form 144 Contineum Therapeutics, Filed by: Stengone Carmine N. June 30, 2026 4:38 PM - SEC Filing Form 144 Contineum Therapeutics, Filed by: Watkins Tim June 30, 2026 4:38 PM - SEC Filing Contineum drug compound PIPE-791 published in medicinal chemistry journal June 30, 2026 4:06 PM - StreetInsider Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry June 30, 2026 4:05 PM - BizWire Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Miralles Gines Diego June 26, 2026 5:46 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Lyons-Williams Lori June 26, 2026 5:45 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Ware Olivia C June 26, 2026 5:45 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Schimmelpennink Evert B. June 26, 2026 5:44 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Ignelzi Troy A. June 26, 2026 5:44 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Brady Todd R. June 26, 2026 5:43 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 26 Filed by: Boyce Sarah June 26, 2026 5:42 PM - SEC Filing Form 8-K Contineum Therapeutics, For: Jun 26 June 26, 2026 4:49 PM - SEC Filing Form 4 Contineum Therapeutics, For: Jun 01 Filed by: Lorrain Daniel S. June 1, 2026 6:09 PM - SEC Filing Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S. June 1, 2026 4:20 PM - SEC Filing Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference June 1, 2026 4:05 PM - BizWire Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P. May 15, 2026 4:44 PM - SEC Filing Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 15, 2026 4:05 PM - BizWire Form SCHEDULE 13G Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P. May 15, 2026 6:41 AM - SEC Filing Contineum Therapeutics (CTNM) PT Raised to $16 at Morgan Stanley May 14, 2026 8:52 AM - StreetInsider Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference May 12, 2026 4:05 PM - BizWire Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference May 11, 2026 4:05 PM - BizWire Contineum Therapeutics, Inc. (CTNM) Tops Q1 EPS by 46c May 5, 2026 5:57 PM - StreetInsider Form 10-Q Contineum Therapeutics, For: Mar 31 May 5, 2026 4:25 PM - SEC Filing Form 8-K Contineum Therapeutics, For: May 05 May 5, 2026 4:10 PM - SEC Filing Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones May 5, 2026 4:05 PM - BizWire Full Article List